Bernstein Upgrades Edwards Lifesciences to Market Perform From Underperform, Adjusts Price Target to $71 From $65
Bernstein Upgrades Edwards Lifesciences to Market Perform From Underperform, Adjusts Price Target to $71 From $65
Bernstein將愛德華生命科學的評級從表現不佳升級到市場表現，將價格目標從65美元調整至71美元
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間